Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Nlc Ventures Netherlands B.V. investment portfolio
Nlc Ventures Netherlands B.V. has made numerous investments in companies such as Garland Surgical, Polynerve, and Osteoweld Surgical within the Healthcare & Life Sciences sector.
vc
Portfolio
78
Team
40
NLC Health Ventures is a European venture builder and investment firm focused on early-stage healthtech innovations originating from universities, hospitals, and corporations. Founded in 2015, the firm employs an entrepreneurial approach at scale by building 25 ventures annually and managing a portfolio of over 100 companies. Through its captive funds, NLC reduces investor risk while accelerating the development of transformative healthcare solutions to market.
Portfolio (78)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Crainio Limited CRAINIO LIMITED develops a non‑invasive intracranial pressure (ICP) monitoring device that uses a forehead‑attached probe to emit near‑infrared light and analyse the returned photoplethysmography signal with machine‑learning algorithms. The device targets clinicians treating traumatic brain injury, offering a safer, cheaper alternative to invasive ICP probes. | Healthcare & Life Sciences | London | Confirmed | 2025-09-20 |
| Foveo Fertility Ltd FOVEO FERTILITY LTD develops a device that maintains physiological temperature and prevents air exposure during oocyte retrieval, aiming to improve egg quality and IVF workflow for fertility clinics. The company targets IVF laboratories and clinicians seeking to enhance fertilisation rates and embryo utilisation. | Healthcare & Life Sciences | London | Confirmed | 2026-03-16 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (7)
Nlc Ventures Netherlands B.V.'s positions across portfolio companies2026
- ORDINARY A 7,167 → 4,000
- A ORDINARY 760 → 0
- A ORDINARY SHARES 0 → 730
Articles (1)
- 23 Aug 2026